You appear to be using an older version of Internet Explorer. We suggest you upgrade your browser for the best viewing experience. Upgrade to a Modern Browser
20 - 24 September 2021
This year's Life Sciences Baltics will be held in digital format. Life Sciences Baltics is the only international forum in the Baltics for world-class biotechnology, pharmaceutical and medical devices experts from all around the world. It provides a unique opportunity to explore the new horizons of partnerships, exchange ideas and seek progress through networking. If you are looking for some advice about patenting or other aspects of intellectual property protection, reach out to Guy Brain , on the networking platform.
23 September 2021
BioForward 2021 will take place LIVE and in-person on Thursday 23 September at The King's Centre in Oxford. BioForward has been specifically designed for growing life sciences R&D companies, and high-quality Service Providers who can provide the critical support and advice required to help them build a commercially sustainable business. This year J A Kemp will be represented by Oxford partner, Amanda Simons. If you have any questions about intellectual property protection, especially patents, please look out for Amanda on the partnering platform or email her direct before or after the event.
7 October 2021
The UN Climate Change Conference (COP 26) is fast approaching and will bring politicians together to accelerate action towards achieving the goals of The Paris Agreement. However, it is the development of new green technologies (greentech) that is key to mitigating the effects of climate change. In recent years, there has been a dramatic growth of greentech with multi-national companies now leading its development. What were once substantially only oil companies are increasingly energy companies with green energy generation projects ranging from wind farms to hydropower. The rise of greentech is clearly demonstrated by the increasing number of patents filed...
13 October 2021
今回のウェビナーではProblem-solutionアプローチの詳細を説明します。 EPO実務では発明の進歩性の有無はProblem-solutionアプローチに沿って判断されます。Problem-solutionアプローチは以下の３つの過程で行われます。 「最も近似する先行技術」を選定する過程 解決すべき「客観的な技術的課題」を設定する過程 最も近似する先行技術及び客観的な技術的課題に基づき当業者にとって本件発明が自明であるかどうかを検討する過程 各過程に関連するファクターをより良く理解することがEPOでの審査をスムーズに進め、望ましい結果を得るうえで有用であると考えます。本ウェビナーでは日欧の進歩性の判断手法を比較し、上の各過程における判断方法を練習問題を交えて解説します。 欧州特許を既に経験されている日本の実務家に向けて少し踏み込んだ内容を３０-４０分程度で解説し、その後質疑応答の時間を用意します。講義資料は日本語です。欧州弁理士が解説を担当する部分は日本語字幕が付きます。質疑応答も日本語で対応します。 無料ウェビナーで特に人数制限もございませんのでご同僚の方々もお誘いのうえご視聴下さい。 クリックしてご登録下さい 。 日程 ２０２１年1 0月1 3日 - 日本時間１８時３０分（イギリス時間９時３０分）
21 October 2021
The Cleantech Ventureday conference is an opportunity to meet and network with the changemakers of the cleantech world and to learn from the very best in the industry. J A Kemp is delighted to be supporting Cambridge Cleantech and Oxfordshire Greentech in a full day of innovative pitches, talks and networking for innovators and investors looking for climate-positive solutions. Attorneys, Hermione Thompson and Joe Simon-Brown are on this year's Advisory Board. The conference is an online event. It will be followed by an in-person reception in Cambridge 5:00 pm – 7:00 pm to network and celebrate together Cambridge Cleantech 10th anniversary.
2 November 2021
Agriculture is an increasingly technology-driven sector in which IP is ever more important. Ag sector IP can relate to a broad range of technologies: from plant breeding and biotechnology, to agri-tech ranging from traditional farm machinery to sophisticated robotics and software/AI, to the chemistry of plant protection products such as herbicides and pesticides. As such, IP considerations vary quite widely both within the ag sector and between that sector and others. The situation is further complicated by the fact that there is not only patent protection to consider, but also other forms of protection such as plant variety rights, contractual...
7 - 9 December 2021
BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences. Jimmy Nicholls, a partner...
7 - 9 December 2021
With 700 international participants from 25+ countries, MedFIT provides the opportunity to connect with international key innovators in the MedTech, diagnostic and digital health sectors. As the leading European partnering event, MedFIT provides the ideal environment to help industry players to source early-stage assets, to facilitate the emergence of collaborative projects between big players, public research institutions, start-ups and SMEs, to increase licensing opportunities, to obtain funding and to facilitate market access. J A Kemp Associate, Christopher O'Beirne will be attending this year's MedFit, online.
9 December 2021
Genesis 2021 will assemble senior executives and decision-makers from across the Life Science, Healthcare and Technology field to present, discuss and demonstrate their collective insight and thought leadership for the sector. Returning face-to-face in a new venue and format to retain positives of in-person and virtual events. There will be a high content mix of dedicated parallel tracks interspersed with plenary talks and panels from key opinion leaders; networking and 1 to 1 meetings, with 600+ delegates from across the international Life Science and Healthcare industry; as well as Innovation Workshops for further technical and business insights. J A Kemp Associate, Guy Brain is attending Genesis...